Combination therapy with nucleoside analogs and alkylating agents

Leukemia

Volumn 8, Issue SUPPL.1, 1994, Pages

  Johnston, James B ^a   Verburg, Linda ^a   Shore, Tsiporah ^a   Williams, Mark ^a   Israels, Lyonel G ^a   Begleiter, Asher ^a  

^a Manitoba Cancer Treatment and Research Foundation   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROPEROXYCYCLOPHOSPHAMIDE; ALKYLATING AGENT; BLEOMYCIN; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; DEOXYADENOSINE; DRUG METABOLITE; NUCLEOSIDE ANALOG; PENTOSTATIN;

ANTINEOPLASTIC ACTIVITY; B CELL LEUKEMIA; BONE MARROW CELL; BONE MARROW PURGING; CELL CULTURE; CHRONIC LYMPHATIC LEUKEMIA; CONFERENCE PAPER; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; DOSE RESPONSE; HUMAN; HUMAN CELL; LEUKEMIA CELL; LYMPHOMA; PRIORITY JOURNAL; X IRRADIATION;

EID: 0028207539     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (20)

1. Foon KA, Rai KR, Gale RP. Chronic lymphocytic leukemia: New insights into biology and therapy. Ann Intern Med 1990; 113:525-539.
2. Hansson J, Lewensohn R, Ringborg U, Nilsson B. Formation and removal of DNA cross-links induced by melphalan and nitrogen mustard in relation to drug-induced cytotoxicity in human melanoma cells. Cancer Res 1987;47:2631-2637.
3. Zwelling LA, Michaels S, Schwartz H, Dobson PP, Kohn KW. DNA cross-linking as an indicator of sensitivity and resistance of mouse L1210 leukemia cells to cis-diamminedichloroplatinum(II) and L-phenylalanine mustard. Cancer Res 1981;41:640-649.
4. Farmer PB. Metabolism and reactions of alkylating agents. Pharmacol Ther 1987;35:301-358.
5. Ho AD, Thaler J, Stryckmans P, Coiffier B, Luciani M, Sonneveld P, Lechner K, Rodenhuis S, Peetermans ME, deCataldo F, De Witte T, Suciu S, Solbu G, Bodewadt-Radzun S, Hunstein W, Zittoun R. Pentostatin in refractory chronic lymphocytic leukemia: A phase II trial of the European Organization for Research and Treatment of Cancer. J Natl Cancer Instit 1990;82:1416-1420.
6. Piro LD, Carrera CJ, Beutler E, Carson DA. 2-Chlorodeoxyadenosine, an effective new agent for the treatment of chronic lymphocytic leukemia. Blood 1988;72:1069-1073.
7. Keating MJ, Kantarjian H, Talpaz M, Redman J, Koller C, Barlogie B, Velasquez W, Plunkett W, Freireich EJ, McCredie K. Fludarabine: A new agent with major activity against chronic lymphocytic leukemia. Blood 1989;74:19-25.
8. O'Dwyer PJ, Wagner B, Leyland-Jones B, Wittes RE, Cheson BD, Hoth DF. 2′-Deoxycoformycin (Pentostatin) for lymphoid malignancies. Ann Int Med 1988;108:733-743.
9. Dighiero G, Travade P, Chevret S, Fenaux P, Chastang C, Binet JL, The French Cooperative Group on CLL. B-cell chronic lymphocytic leukemia: Present status and future directions. Blood 1991;78:1901-1914.
10. Santos GW, Colvin OM. Pharmacological purging of bone marrow with reference to autografting. Clin Hematol 1986;15:67-83.
11. Begleiter A, Pugh L, Israels LG, Johnston JB. Enhanced cytotoxicity and inhibition of DNA damage repair in irradiated murine L5178Y lymphoblasts and human chronic lymphocytic leukemia cells treated with 2′-deoxycoformycin and deoxyadenosine in vitro. Cancer Res 1988;48:3981-3986.
12. Begleiter A, Peniuk H, Verburg L, Johnston JB. Inhibition of repair of bleomycin-induced DNA damage by deoxyadenosine and 2′-deoxycoformycin. Biochem Pharmacol 1992;44:2229-2233.
13. Falkoff RM, Peters M, Fauci AS. T cell enrichment and depletion of human peripheral blood mononuclear cell preparations. Unexpected findings in the study of the functional activities of the separated populations. J Immunol Methods 1982;50:39-49.
14. Johnston JB, Begleiter A, Pugh L, Leith MK, Wilkins JA, Cavers DJ, Israels LG. The biochemical changes induced in hairy-cell leukemia by the adenosine deaminase inhibitor 2′-deoxycoformycin. Cancer Res 1986;46: 2179-2184.
15. Kirkpatrick DL, Duke M, Goh TS. Chemosensitivity testing of fresh human leukemia cells using both a dye exclusion assay and a tetrazolium dye (MTT) assay. Leuk Res 1990;14:459-466.
16. Petzer AL, Bilgeri R, Zilian U, Haun M, Geisen FH, Pragnell I, Braunsteiner H, Konwalinka G. Inhibitory effect of 2-chlorodeoxyadenosine on granulocytic, erythroid and T-lymphocytic colony growth. Blood 1991;78:2583-2587.
17. Coulombel L, Eaves AC, Eaves CJ. Enzymatic treatment of long-term human marrow cultures reveals the preferential location of primative hemopoietic progenitors in the adherent layer. Blood 1983;62:291-297.
18. Begleiter A, Goldenberg GJ, Anhalt CD, Lee K, Mowat MRA, Israels LG, Johnston JB. Mechanisms of resistance to chlorambucil in chronic lymphocytic leukemia. Leuk Res 1991;15:1019-1027.
19. Begleiter A, Lee K, Israels LG, Mowat MRA, Johnston JB. Chlorambucil (CLB) induced apoptosis in chronic lymphocytic leukemia (CLL) and clinical efficacy. Proc Amer Assoc Cancer Res 1993;34:288.
20. + prolymphocytic leukemia by deoxyadenosine and 2′-deoxycoformycin. Leuk Res 1992;16:781-788.